"Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis

Infection Control and Hospital Epidemiology

Volumn 20, Issue 11, 1999, Pages 741-745

  Mylotte, Joseph M ^a,b   Kahler, Lucinda ^b   Jackson, Ellen ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ERIE COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PSEUDOMONIC ACID;

ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; NOSE; OINTMENT; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIDDLE AGED; MUPIROCIN; NOSE; OINTMENTS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; STAPHYLOCOCCAL INFECTIONS;

EID: 0033227801     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501575     Document Type: Article

References (10)

1. Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis 1994;23:569-573.
2. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
3. Sewell CM, Clarridge J, Lacke C, Weinman EJ, Young EJ. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982;248:1493-1495.
4. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989;9:61-64.
5. Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990;322:505-509.
6. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993;13(suppl 2):S332-S334.
7. Herwaldt LA. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections. Perit Dial Int 1993;13(suppl 2):S301-S305.
8. Lye WC, Leong SO, van der Straaten J, Lee EJ. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994;10:163-165.
9. Oxton LL, Zimmerman SW, Roecker EB, Wakeen M. Risk factors for peritoneal dialysis-related infections. Perit Dial Int 1994;14:137-144.
10. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991;18:225-231.